Pure Global

Amikacin Quantitative Testing Drug - Vietnam Registration 2403571ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Amikacin Quantitative Testing Drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TBYT Loại C medical device is registered under number 2403571ĐKLH/BYT-HTTB and manufactured by Roche Diagnostics GmbH. The authorized representative in Vietnam is CÔNG TY TNHH ROCHE VIỆT NAM.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2403571ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2403571ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Amikacin Quantitative Testing Drug
VN: Thuốc thử xét nghiệm định lượng amikacin
Risk Class TBYT Loại C

Registration Details

2403571ĐKLH/BYT-HTTB

000.00.04.G18-240827-0006

AMIK2

08105383190

Company Information

GERMANY

Technical Details

In vitro testing used to quantify amikacin in plasma and serum on various cobas systems.

Dates and Status

Nov 14, 2024